US Patent RE45174 Thiazolidin-4-one derivatives
Patent RE45174 was granted and assigned to Actelion on September, 2014 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent RE45174 Thiazolidin-4-one derivatives
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
